These batokines including Nrg4 have been shown to improve metabolic diseases such as NAFLD, atherosclerosis, and diabetes (Cereijo et al., 2020; Spann et al., 2021; Liu et al., 2022). Here, NRG4 is linked to metabolic dysfunction-associated steatotic liver disease.